Subscribe to RSS
DOI: 10.1055/s-2001-18427
Chronic Allograft Rejection (Obliterative Bronchiolitis)
Publication History
Publication Date:
14 November 2001 (online)
![](https://www.thieme-connect.de/media/srccm/200105/lookinside/thumbnails/10.1055-s-2001-18427-1.jpg)
ABSTRACT
Lung and heart-lung transplantation are currently recognized as effective treatment for selected patients with end-stage lung or heart-lung disease. Although the survival rates have improved in recent years, long-term survival is still hampered by the development of chronic rejection. Histologically chronic rejection is manifested by obliterative bronchiolitis (OB), a process that leads to airways obstruction, with a gradual decline in pulmonary function tests. Extensive research efforts have attempted to unravel the pathophysiology of OB and identify key cytokines and growth factors involved in the process. Since the hisotological diagnosis of chronic rejection remains difficult, a clinical grading system has been proposed, determined as bronchiolitis obliterans syndrome (BOS), divided into four and, more recently, five categories, depending on the severity of airflow obstruction. This paper reviews the current knowledge of chronic rejection after heart-lung and lung transplantation.
KEYWORD
Chronic rejection - obliterative bronchiolitis - bronchiolitis obliterans syndrome
REFERENCES
- 1 Hosenpud J D, Bennett L E, Keck B M, Boucek M M, Novick R J. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000. J Heart Lung Transplant . 2000; 19 909-931
- 2 Cooper J D, Billingham M, Egan T. A working formulation for the standardization of nomenclature for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant . 1993; 12 713-716
- 3 Reichenspurner H, Girgis R E, Robbins B C. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg . 1996; 62 1467-1472
- 4 Meyers B F, Lynch J, Trulock E P, Guthrie T J, Cooper J D, Patterson G A. Lung transplantation: a decade of experience. Ann Surg . 1999; 230 362-370
- 5 Whitehead B, Rees P, Sorensen K. Incidence of obliterative bronchiolitis after heart-lung transplantation in children. J Heart Lung Transplant . 1993; 12 903-908
- 6 Van Raemdonck D, Verleden G, Vanhaecke J. The current status of lung transplantation. Acta Chir Austriaca . 1999; 31 292-301
- 7 Tamm M, Sharples L, Higenbottam T, Steward S, Wallwork J. Bronchiolitis obliterans syndrome (BOS) following heart- lung transplantation. Transpl Int . 1996; 9(suppl 1) S299-S302
- 8 Kroshus T J, Kshettry V R, Savik K, Ranjit J, Hertz M I, Bolman R M. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg . 1997; 114 195-202
- 9 Stanbrook M B, Kesten S. Bronchial hyperreactivity after lung transplantation predicts early bronchiolitis obliterans. Am J Respir Crit Care Med . 1999; 160 2034-2039
- 10 Kshettry V R, Kroshus T J, Savik K, Hertz M I, Bolman R M. Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients. Chest . 1996; 110 704-709
- 11 Hirt S W, You X M, Moller F. Development of obliterative bronchiolitis after allogeneic lung transplantation: implication of acute rejection and the time point of treatment. J Heart Lung Transplant . 1999; 18 542-548
- 12 Bando K, Paradis I L, Similo S. Obliterative bronchiolitis after lung and heart-lung transplantation: an analysis of risk factors and management. J Thorac Cardiovasc Surg . 1995; 110 4-13
- 13 Husain A N, Siddique M T, Holmes E W. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med . 1999; 159 829-833
- 14 Ross D J, Marchevsky A, Kramer M, Kass R M. ``Refractoriness'' of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts. J Heart Lung Transplant . 1997; 16 832-838
- 15 Verleden G M. Bronchiolitis obliterans syndrome after lung transplantation: medical treatment. Monaldi Arch Chest Dis . 2000; 55 140-145
- 16 Quantz M A, Bennett L E, Meyer D M, Novick R J. Does human leukocyte antigen matching influence the outcome of lung transplantation?. <~>An analysis of 3549 lung transplantations. J Heart Lung Transplant . 2000; 19 473-479
- 17 Schulan L L, Weinberg A D, McGregor C, Galantowicz M E, Suciu-Foca N M, Itescu S. Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation. Am J Respir Crit Care Med . 1998; 157 1833-1837
- 18 Smith M A, Sundaresan S, Mohanakumar T. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg . 1998; 116 812-820
- 19 Girgis R E, Tu I, Berry G J. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant . 1996; 15 1200-1208
- 20 Soghikian M V, Valentine V G, Berry G J, Patel H R, Robbins R C, Theodore J. Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients. J Heart Lung Transplant . 1996; 15 881-887
- 21 Reichenspurner H, Soni V, Nitschke M. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus. J Heart Lung Transplant . 1998; 17 439-451
- 22 Baudet E M, Dromer C, Dubrez J. Intermediate-term results after en bloc double-lung transplantatoin with bronchial arterial revascularisation. J Thorac Cardiovas Surg . 1996; 112 1292-1299
- 23 Yacoub M, Al-Kttan K M, Tadjkarimi S, Eren T, Khaghani A. Medium term results of direct bronchial arterial revascularization using IMA for single lung transplantation (SLT) with direct revascularisation. Eur J Cardiothor Surg . 1997; 11 1030-1036
- 24 Norgaard M A, Andersen C B, Pettersson G. Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?. Eur J Cardiothor Surg . 1998; 14 311-317
- 25 Daly R C, McGregor C GA, McDougall J C, Midthun D E, Peters S G, Scott J P. Bronchial artery revascularization does not prevent bronchiolitis obliterans syndrome after lung transplantation. Proceedings 3rd International Congress on Lung Transplantation, Paris, September 10-11, 1995: 022
- 26 DiGiovine B, Lynch III P J, Martinez F J. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation. J Immunol . 1996; 157 4194-4202
- 27 Riise G C, Andersson B A, Kjellstrom C. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplantation. Eur Respir J . 1999; 14 1123-1130
- 28 Ward C, Snell G I, Zheng L. Endobronchial biopsy and bronchoalveolar lavage in stable lung transplant recipients and chronic rejection. Am J Respir Crit Care Med . 1998; 158 84-91
- 29 Hirsch J, Elssner A, Mazyr G. Bronchiolitis obliterans syndrome after (heart)-lung transplantation: impaired antiprotease defense and increased oxidant activity. Am J Respir Crit Care Med . 1999; 160 1640-1646
- 30 Behr J, Maier K, Braun B, Schwaiblmair M, Vogelmeier C. Evidence for oxidative stress in bronchiolitis obliterans syndrome after lung and heart-lung transplantation. Transplantation . 2000; 69 1856-1860
- 31 McDermott C D, Gavita S M, Shennib H, Giaid A. Immunohistochemical localization of nitric oxide synthase and the oxidant peroxynitrite in lung transplant recipients with obliterative bronchiolitis. Transplantation . 1997; 64 270-274
- 32 Mason N A, Springall D R, Pomerance A, Evans T J, Yacoub M H, Polak J M. Expression of inducible nitric oxide synthase and formation of peroxynitrite in posttransplant obliterative bronchiolitis. J Heart Lung Transplant . 1998; 17 710-714
- 33 Mauck K A, Hosenpud J D. The bronchial epithelium: a potential allogeneic target for chronic rejection after lung transplantation. J Heart Lung Transplant . 1996; 15 709-714
- 34 Borger P, Kauffman H F, Timmerman J A, Scholma J, van den Berg W J, Koeter G H. Cyclosporine, FK506, mycophenolate mofetil, and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial cells. Transplantation . 2000; 69 1408-1413
- 35 Snell G I, Ward C, Wilson J W, Orsida B, Williams T J, Walters E H. Immunopathologic changes in the airways of stable lung transplant recipients. Thorax . 1997; 52 322-328
- 36 Neuringer I P, Walsh S P, Mannon R B, Gabriel S, Aris R M. Enhanced T cell cytokine gene expression in mouse airway obliterative bronchiolitis. Transplantation . 2000; 69 399-405
- 37 Neuringer I P, Mannon R B, Coffman T M. Immune cells in a mouse airway model of obliterative bronchiolitis. Am J Respir Cell Mol Biol . 1998; 19 379-386
- 38 Hertz M I, Henke C A, Nakhleh R E. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc Natl Acd Sci USA . 1992; 89 10385-10389
- 39 Jonosono M, Fang K C, Keith F M. Measurement of fibroblast proliferative activity in bronchoalveolar lavage fluid in the analysis of obliterative bronchiolitis among lung transplant recipients. J Heart Lung Transplant . 1999; 18 972-985
- 40 Romanska H M, Ikonen T S, Bishop A E, Morris R E, Polak J M. Up-regulation of inducible nitric oxide synthase in fibroblasts parallels the onset and progression of fibrosis in an experimental model of post-transplant obliterative airway disease. J Pathol . 2000; 191 71-77
- 41 Sundaresan S, Mohanakumar T, Smith M A. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation . 1998; 65 648-653
- 42 Elssner A, Jaumann F, Dobmann S. Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Transplantation . 2000; 70 362-367
- 43 Lee A G, Wagner F M, Giaid A. Immunohistochemical characterization of inflammatory and proliferative events during chronic rejection in rat lung allografts. Transplantation . 1997; 64 465-471
- 44 El Gamel A, Sim E, Hasleton P. Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant . 1999; 18 828-837
- 45 Charpin J M, Stern M, Grenet D, Israel-Biet D. Insulin-like growth factor-1 in lung transplants with obliterative bronchiolitis. Am J Respir Crit Care Med . 2000; 161 1991-1998
- 46 Glanville A R, Baldwin J C, Burke C M, Theodore J, Robin E D. Obliterative bronchiolitis after heart-lung transplantation: apparent arrest by augmented immunosuppression. Ann Int Med . 1987; 107 300-304
- 47 Van den Berg W J, Geertsma A, van der Bij W. Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life. Am J Respir Crit Care Med . 2000; 161 1937-1941
- 48 Kelly K, Hertz M I. Obliterative bronchiolitis. Clin Chest Med . 1997; 18 319-337
- 49 Pomerance A, Madden B, Burke M M, Yacoub M H. Transbronchial biopsy in heart and lung transplantation: clinicopathologic correlations. J Heart Lung Transplant . 1995; 14 761-763
- 50 Kramer M R, Stoehr C, Wang J L. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial biopsies. J Heart Lung Transplant . 1993; 12 675-681
- 51 Patterson G M, Wilson S, Whang J L. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. J Heart Lung Transplant . 1996; 15 175-181
- 52 Reynaud-Gaubert M, Thomas P, Badier M, Cau P, Giudicelli R, Fuentes P. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation: functional and bronchoalveolar lavage findings. Am J Respir Crit Care Med . 2000; 161 1924-1929
- 53 Maurer J, Estenne M, co-chairs. BOS reclassification. Draft: 2000
- 54 Ikonen T, Kivisaari L, Taskinen E, Piilonen A, Harjula A L. High-resolution CT in long-term follow-up after lung transplantation. Chest . 1997; 111 370-376
- 55 Estenne M, Van Muylem A, Knoop C, Antoine M. Detection of obliterative bronchiolitis after lung transplantation by indexes of ventilation distribution. Am J Respir Crit Care Med . 2000; 162 1047-1051
- 56 Verleden G M, Dupont L J, Lamont J. Is there a role for measuring exhaled nitric oxide in lung transplant recipients with chronic rejection?. J Heart Lung Transplant . 1998; 17 231-232
- 57 Fisher A J, Gabbay E, Small T, Doig S, Dark J H, Corris P A. Cross-sectional study of exhaled nitric oxide levels following lung transplantation. Thorax . 1998; 53 454-458
- 58 Verleden G M, Dupont L, Delcroix M. Exhaled nitric oxide (eNO) and lung transplantation: impact of the native lung?. Eur Respir J . 2001; 18(suppl 33) 179-180
- 59 Verleden G M, Delcroix M, Buyse B, Dupont L, and the Leuven Lung Transplant Group. Exhaled NO (eNO) after lung transplantation (LTx): a prospective study. J Heart Lung Transplant . 2001; 20 208
- 60 Valentine V G, Robbins R C, Berry G J. Actuarial survival of heart-lung and bilateral lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant . 1996; 15 371-383
- 61 Reichenspurner H, Girgis R E, Robbins R C. Obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg . 1995; 60 1845-1853